Thermo Fisher Scientific Expands Oncomine Portfolio for Liquid Biopsy and Immuno-Oncology Clinical Research
New pan-cancer cell-free total nucleic acid (cfTNA) assay and FFPE-based tumor mutation load analysis assay
New pan-cancer cell-free total nucleic acid (cfTNA) assay and FFPE-based tumor mutation load analysis assay
Josh Haimes, technical lead at ArcherDX, explains how successful NGS is influenced by step-by-step quality control
From cancer cells to ocean microbes to Zika virus: Read the interviews that made the most impact in 2017
Dr. Michael Bianchi, senior lab manager at Empire Genomics explains the fundamental basis of a successful experiment – a protocol that works well.
Dr. Bruce Conklin, UCSF, discusses the potential of genome engineering as a therapy for genetic diseases
Dr. Stephen Chanock, National Cancer Institute, shares the latest cancer epidemiology studies at the NIH and the team’s hopes of being able to predict and prevent disease
New CRISPR screening services substantially broaden range of possible genetic studies
Catch-up on this week’s top Life Sciences content
Bioline Launches New JetSeq™ Clean Kit for Next-Generation Sequencing
The next BIG prize drawing is only days away - simply write a laboratory product review today for your chance to win a $400 Amazon voucher or an iPad
Extended RAS Panel helps identify colorectal cancer patients eligible for Amgen’s Vectibix
By Guest Editor Jung Doh, Senior Applications Scientist, Beckman Coulter Life Sciences.
Thermo Fisher to introduce Ion AmpliSeq™ On-Demand product line of pre-tested gene targets and several other new Ion Torrent NGS offerings at ESHG 2017
Expanding environmental microbial phylogeny with single cell genomics and metagenomics
Discover how this leading London Biomedical Research Center is using state-of-the-art genomics to improve healthcare